Projects / Programmes
Zdravljenje malignih solidnih tumorjev z interferonom alfa (Slovene)
Code |
Science |
Field |
Subfield |
3.04.00 |
Medical sciences |
Oncology |
|
Code |
Science |
Field |
B007 |
Biomedical sciences |
Medicine (human and vertebrates) |
B200 |
Biomedical sciences |
Cytology, oncology, cancerology |
interferon alfa, chemoimmunotherapy, immunopotentiation, NK cells
Organisations (1)
, Researchers (8)
0302 Institute of Oncology Ljubljana
Abstract
The aim of study is to establish the effect of addition of IFN-alfa to cisplatin, vinblastine, 5-fluorouracil or paclitaxel on survival of patients with metastatic melanoma, renal cancer, lung cancer and head and neck cancer. Combined treatment effect will be evaluaated by clinical parameters (response rate, duration of survival and time to progression) and immunologically (determination of lymphocytes CD4, Th1, Th2, CD8, NK cells and activity of NK cells).